Day: April 1, 2024

Geneva, Switzerland, April 01, 2024 (GLOBE NEWSWIRE) — SEALSQ Corp (“SEALSQ” or “Company”) (NASDAQ: LAES), a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum technology hardware and software products, today announced that its PKI-as-a-Service solution “INeS” has been selected by D-Link, a global leader in networking solutions, to provide Node Attestation Certificates for D-Link’s MS30-N, MS30, and MS60-I Matter-compliant IoT Gateways. “SEALSQ’s INeS platform enables D-Link MS30-N, MS30, and MS60 IoT gateways to offer features like faster connection to a Matter ecosystem for the devices they manufacture. Additionally, it provides higher flexibility for D-Link to manage certificates at design and manufacturing stages,” said Frank Buonnano, VP of Global Sales for SEALSQ. He...

VANCOUVER, British Columbia, April 01, 2024 (GLOBE NEWSWIRE) — AlphaGen Intelligence Corp. (CSE: AIC | OTC: APETF | FSE: W4V) (“AlphaGen” or the “Company”), a leader in AI technology for 3D entertainment, ecommerce, and content is excited to announce the beta launch of the world’s largest virtual beauty metropolis. This marks a significant milestone in AlphaGen’s journey, following the multi-million dollar contract with a major retail client beginning in 2023. The virtual beauty metropolis elevates ecommerce experiences by offering an immersive platform for brands that bridges the gap between virtual and physical beauty retail. AlphaGen’s approach to creating virtual worlds underscores the company’s leadership in capitalizing on the Metaverse opportunity, which Citibank projects could be worth up to $13 trillion by...

DUBLIN, Ireland, April 01, 2024 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the 23rd Annual Needham Healthcare Conference on Monday, April 8 at 10:15 a.m. ET. A live webcast of the fireside chat, as well as an archived recording, will be available on Avadel’s Investor Relations website, investors.avadel.com, for 90 days following the conference. About Avadel Pharmaceuticals plc Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment...

MONTREAL and CHARLOTTE, N.C., April 01, 2024 (GLOBE NEWSWIRE) — Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that it will present data on etripamil at two upcoming cardiology conferences this month. The company will deliver oral and poster presentations at the American College of Cardiology annual meeting (ACC24), to be held April 6-8th in Atlanta, Georgia, and a poster presentation at the annual meeting of the European Heart Rhythm Association (EHRA), to be held April 7-9th in Berlin, Germany. The presentations will be available following the embargo at https://MilestonePharma.com.ACC Presentation Details: Oral Presentation Title:   Multi-Center, Open-Label Study of the Efficacy and Safety...

MALVERN, Pa., April 01, 2024 (GLOBE NEWSWIRE) — Vishay Intertechnology, Inc., (NYSE: VSH) announced today that its Annual Meeting of Stockholders will be held at 9:00 a.m., U.S. eastern time, on Tuesday, May 21, 2024. Vishay has adopted a virtual annual meeting in 2024. The annual meeting will be accessible to stockholders via the Internet at www.virtualshareholdermeeting.com/VSH2024.  United States Securities and Exchange Commission rules allow the Company to mail a notice to its stockholders advising that its proxy statement, annual report to stockholders, electronic proxy card and related materials are available for viewing, free of charge, on the Internet. Stockholders may then access these materials and vote over the Internet or request delivery of a full set of materials by mail or email. Vishay has elected to utilize this...

LANGHORNE, Pa., April 01, 2024 (GLOBE NEWSWIRE) — NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced its financial results for the fourth quarter and full year ended December 31, 2023. Adam Levy, NEXGEL’s Chief Executive Officer, commented, “2023 was a record year for NEXGEL and transformational in many respects. Our nearly 100% year-over-year revenue growth in 2023 was primarily driven by our branded products and contract manufacturing. Over the course of the year and into our current first quarter, we have significantly expanded our operational infrastructure, solidified several key strategic partnerships with multi-billion-dollar corporations and made key strategic investments, that collectively...

Tel Aviv, Israel, April 01, 2024 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq: MDGS), a technology-based company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, is excited to announce a landmark achievement by its subsidiary, Charging Robotics Ltd. Which has successfully completed the installation of its wireless charging system for an automated parking system (APS). To the best of Charging Robotics’ knowledge, this is the first installation of a wireless charging system for automatic car parks. Charging Robotics Ltd. (“Charging Robotics”), a subsidiary of Fuel Doctor Holdings, Inc., (“FDOC”) a Delaware corporation listed on the OTC Market (66.84% owned by Medigus) is an innovative wireless charging solutions company for electric vehicles (EVs) The installation, previously...

MELVILLE, N.Y., April 01, 2024 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based therapies, announced today the filing of its Form 10-K annual report with the Securities and Exchange Commission (“SEC”) for the year ended December 31, 2023. The annual report can be accessed on the SEC’s website at www.sec.gov, and on the Company’s website at www.biorestorative.com under “SEC Filing” in the Investors and Media section. 2023 and Recent Pipeline Developments BioRestorative’s two primary platform technologies include: its lead clinical-stage cell therapy candidate, BRTX-100, which consists of 40 million autologous bone marrow-derived, hypoxic-cultured transitional stem cells combined with...

BENTONVILLE, Ark., April 01, 2024 (GLOBE NEWSWIRE) — Glucose Health, Inc. (OTC: GLUC) is pleased to announce the expansion of its innovative Fiber Up® brand of soluble fiber supplements, just launched in November 2023, with the introduction of two new drink mix flavors plus a new product format of Fiber Up® gumdrops – all to be available for purchase shortly via Amazon. The two new drink mix flavors, Fiber Up® Tropical and Fiber Up® Fruit Punch, are formulated to provide consumers with refreshing and delicious options to support metabolic health with soluble nutrition. These new Fiber Up® flavors combine the clinically benefits of soluble fiber with delicious taste, making it easier for individuals to incorporate fiber into their daily routines. Tropical offers a burst of exotic fruit flavors, while Fruit Punch delivers a classic,...